Valo Therapeutics Ltd announced that it has received $12.75 million in an oversubscribed Pre-IPO round of funding on November 15, 2021. The transaction included participation from new investor, MMJ Group Holdings Limited and existing investor, Freeman Road Pty Ltd. The company has received $25.5 million in funding till date.